Popular
Simple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
CME/CESimple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
Karen E. Anderson, MD
Hubert H. Fernandez, MD
The Clinical Consequences of Delayed Colorectal Cancer Screening
Clinician's RoundtableThe Clinical Consequences of Delayed Colorectal Cancer Screening
Peter Buch, MD, FACG, AGAF, FACP
Christopher Cann, MD
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Early Arthritis Insights from the CATCH Cohort
Living RheumEarly Arthritis Insights from the CATCH Cohort
Louis Bessette MD, FRCP(C), MSc
Key Advances in Rheumatology at CCR East 2026
Living RheumKey Advances in Rheumatology at CCR East 2026
Louis Bessette MD, FRCP(C), MSc
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Programs
Shared Decision-Making in Colorectal Cancer Screening
Clinician's RoundtableShared Decision-Making in Colorectal Cancer Screening
Gates B. Colbert, MD
Sarina Schrager, MD
Lashika Yogendran, MD
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Living RheumSpot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
Key Advances in Rheumatology at CCR East 2026
Living RheumKey Advances in Rheumatology at CCR East 2026
Louis Bessette MD, FRCP(C), MSc
Rethinking Potassium Restriction in Chronic Kidney Disease Management
Clinician's RoundtableRethinking Potassium Restriction in Chronic Kidney Disease Management
Deborah Clegg, PhD
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
Clinical Practice
Simple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
CME/CESimple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
Karen E. Anderson, MD
Hubert H. Fernandez, MD
How Delayed Colorectal Cancer Screening Impacts Quality of Life
Clinician's RoundtableHow Delayed Colorectal Cancer Screening Impacts Quality of Life
Christopher Cann, MD
Endobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Clinician's RoundtableEndobronchial Valve Therapy in COPD: Selection Criteria and Safety Insights
Frank C. Sciurba, MD, FCCP
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Psoriasis and Mental Health: Why Whole-Patient Care Matters
On the Frontlines of PsoriasisPsoriasis and Mental Health: Why Whole-Patient Care Matters
Steve Jackson, PharmD
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
MinuteCE®Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Jennifer Johnson, MD, PhD
Doctors Lounge
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
The Convergence“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
Brian P. McDonough, MD, FAAFP
Kate Rouch
Rehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
MAPSChatsRehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
Matt Birnholz, MD
Dr. Susanna Gallani
Combatting Challenges & Health Disparities in Colorectal Cancer Care
Project Oncology®Combatting Challenges & Health Disparities in Colorectal Cancer Care
Jacob Sands, MD
Edith Mitchell, MD, MACP, FCPP, FRCP
Designing Smarter Insight Frameworks in Medical Affairs
MAPSChatsDesigning Smarter Insight Frameworks in Medical Affairs
Matt Birnholz, MD
Tony Page
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChatsOptimizing Medical Affairs Approaches with CME Best Practices
Matt Birnholz, MD
Karen Roy, MSc
CME
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CEImproving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE
Samir Dalia, MD
Christopher Jurief
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CESjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CERedefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
Industry Feature
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
BRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Medical Industry FeatureBRCA and HRD Biomarker Testing in Advanced Ovarian Cancer: A KOL Panel Discussion
Sharyn N. Lewin, MD, FACS, FACOG
Dana Chase, MD
Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Medical Industry FeatureAdvancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real-World Analyses Tell Us
Jennifer Caudle, DO, FACOFP
Seth Wander, MD, PhD